A detailed history of Northwest Financial Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Northwest Financial Advisors holds 2,887 shares of NVO stock, worth $306,397. This represents 0.27% of its overall portfolio holdings.

Number of Shares
2,887
Previous 3,334 13.41%
Holding current value
$306,397
Previous $476 Million 27.77%
% of portfolio
0.27%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $53,224 - $65,002
-447 Reduced 13.41%
2,887 $344 Million
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $16,688 - $19,979
136 Added 4.25%
3,334 $476 Million
Q1 2024

May 09, 2024

BUY
$102.11 - $135.92 $77,093 - $102,619
755 Added 30.9%
3,198 $411 Million
Q4 2023

Feb 07, 2024

BUY
$87.78 - $105.45 $214,446 - $257,614
2,443 New
2,443 $253 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Northwest Financial Advisors Portfolio

Follow Northwest Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Financial Advisors with notifications on news.